PURPOSE: In anticipation of oncologist workforce shortages projected as part of a 2007 study, the American Society of Clinical Oncology (ASCO) worked with a contractor to create a workforce information system (WIS) to assemble the latest available data on oncologist supply and cancer incidence and prevalence. ASCO plans to publish findings annually, reporting on new data and tracking trends over time. METHODS: THE WIS REPORT IS COMPOSED OF THREE SECTIONS: supply, new entrants, and cancer incidence and prevalence. Tabulations of the number of oncologists in the United States are derived mainly from the American Medical Association Physician Masterfile. Information on fellows and residents in the oncology workforce pipeline come from published sources such as Journal of the American Medical Association. Incidence and prevalence estimates are published by the American Cancer Society and National Cancer Institute. RESULTS: The WIS reports a total of 13,084 oncologists working in the United States in 2011. Oncologists are defined as those physicians who designate hematology, hematology/oncology, or medical oncology as their specialty. The WIS compares the characteristics of these oncologists with those of all physicians and tracks emerging trends in the physician training pipeline. CONCLUSION: Observing characteristics of the oncologist workforce over time allows ASCO to identify, prioritize, and evaluate its workforce initiatives. Accessible figures and reports generated by the WIS can be used by ASCO and others in the oncology community to advocate for needed health care system and policy changes to help offset future workforce shortages.
PURPOSE: In anticipation of oncologist workforce shortages projected as part of a 2007 study, the American Society of Clinical Oncology (ASCO) worked with a contractor to create a workforce information system (WIS) to assemble the latest available data on oncologist supply and cancer incidence and prevalence. ASCO plans to publish findings annually, reporting on new data and tracking trends over time. METHODS: THE WIS REPORT IS COMPOSED OF THREE SECTIONS: supply, new entrants, and cancer incidence and prevalence. Tabulations of the number of oncologists in the United States are derived mainly from the American Medical Association Physician Masterfile. Information on fellows and residents in the oncology workforce pipeline come from published sources such as Journal of the American Medical Association. Incidence and prevalence estimates are published by the American Cancer Society and National Cancer Institute. RESULTS: The WIS reports a total of 13,084 oncologists working in the United States in 2011. Oncologists are defined as those physicians who designate hematology, hematology/oncology, or medical oncology as their specialty. The WIS compares the characteristics of these oncologists with those of all physicians and tracks emerging trends in the physician training pipeline. CONCLUSION: Observing characteristics of the oncologist workforce over time allows ASCO to identify, prioritize, and evaluate its workforce initiatives. Accessible figures and reports generated by the WIS can be used by ASCO and others in the oncology community to advocate for needed health care system and policy changes to help offset future workforce shortages.
Authors: Elaine L Towle; Thomas R Barr; Amy Hanley; Michael Kosty; Stephanie Williams; Michael A Goldstein Journal: J Oncol Pract Date: 2011-09 Impact factor: 3.840
Authors: Tait D Shanafelt; Marilyn Raymond; Leora Horn; Tim Moynihan; Frances Collichio; Helen Chew; Michael P Kosty; Daniel Satele; Jeff Sloan; William J Gradishar Journal: J Clin Oncol Date: 2014-09-20 Impact factor: 44.544
Authors: Joan L Warren; Michael J Barrett; Dolly P White; Robert Banks; Susannah Cafardi; Lindsey Enewold Journal: J Natl Cancer Inst Monogr Date: 2020-05-01
Authors: Samuel U Takvorian; Erin Balogh; Sharyl Nass; Virginia L Valentin; Lori Hoffman-Hogg; Randall A Oyer; Robert W Carlson; Neal J Meropol; Lisa Kennedy Sheldon; Lawrence N Shulman Journal: J Natl Cancer Inst Date: 2020-07-01 Impact factor: 13.506
Authors: Mitchell S von Itzstein; Mary L Smith; Elda Railey; Carol B White; Julianne S Dieterich; Liz Garrett-Mayer; Suanna S Bruinooge; Andrew N Freedman; Janet De Moor; Stacy W Gray; Jason Y Park; Jingsheng Yan; Anh Quynh Hoang; Hong Zhu; David E Gerber Journal: JCO Oncol Pract Date: 2021-05-10